101. Construction of the Korea Elderly Pharmacoepidemiologic Cohort: drug utilization review of cephalosporins in geriatric inpatients
- Author
-
Byung Joo Park, Sun Ah Kim, and Yong Kyun Cho
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,Databases, Factual ,Epidemiology ,medicine.drug_class ,Cephalosporin ,Antibiotics ,Drug Prescriptions ,Cohort Studies ,Antibiotic resistance ,Drug Utilization Review ,Sex Factors ,Risk Factors ,Internal medicine ,Surveys and Questionnaires ,Health care ,medicine ,Humans ,Pharmacology (medical) ,Medical prescription ,Aged ,Aged, 80 and over ,Inpatients ,Korea ,business.industry ,Age Factors ,Cephalosporins ,Treatment Outcome ,Cohort ,Population study ,Female ,business - Abstract
We performed a cohort-based pharmacoepidemiologic study in order to evaluate the pattern of cephalosporin prescriptions in elderly inpatients in Korea. The Korea Elderly Pharmacoepidemiologic Cohort was composed of a geriatric population of beneficiaries of the Korea Medical Insurance Corporation residing in Busan in 1993. The cohort consisted of 23 649 members, comprising 15 221 women (64.4%) and 8428 men (35.6%). The study population for drug utilization review consisted of those cohort members who were admitted into hospitals during the period January 1993 through December 1994. The number of hospitalized patients was 4262, comprising 2631 women (61.7%) and 1681 men (38.3%). The trend of cephalosporin prescriptions over the 2-year period showed that the use of second and third generation cephalosporins increased relative to the use of first generation. The use of cephalosporins combined with other antibiotics was found to occur in 22.8% aminoglycosides (76.7%) and quinolones (17.1%) being the most common antibiotics combined with cephalosporins. Our result demonstrates an increase in the prescription of second and third generation cephalosporins in Korea, which has implications not only for the elderly population but also for the total population because of the impact on health care costs and the potential for the emergence of antimicrobial resistance. Copyright © 2001 John Wiley & Sons, Ltd.
- Published
- 2002